Furthermore, IGF-IR was differentially expressed in human sarcomas, and the targeted blockade of the IGF-IR pathway inhibited human osteosarcoma migration through downregulation of MMP-2 and -9 expression [158]. The gene discussed is IGF1R; the disease is sarcoma.